NCT06799806

Brief Summary

Bronchial fibroscopy is a frequently used procedure in the management of pneumology patients, and can be a source of anxiety, particularly while waiting for the examination. Investigator's professional experience has shown us that many patients are anxious in the waiting room before a flexible bronchoscopy in vigile. A great deal of research has been carried out into the use of virtual reality to reduce anxiety and pain during care but shortly before bronchoscopy. The innovative aspect is to target the patient's waiting time for the examination. Waiting is a highly anxiety-provoking time, and nurses play a vital role in supporting patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 20, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 29, 2025

Completed
29 days until next milestone

Study Start

First participant enrolled

February 27, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 27, 2026

Completed
Last Updated

March 24, 2025

Status Verified

March 1, 2025

Enrollment Period

1 year

First QC Date

January 20, 2025

Last Update Submit

March 19, 2025

Conditions

Keywords

virtual reality headsetanxiety

Outcome Measures

Primary Outcomes (1)

  • Anxiety assessment

    Anxiety assessment is measured using a Numerical Rating Scale (NRS) from 0 to 10, supplemented by a self-assessment questionnaire before and after using the Therapeutic Virtual Reality Headset.

    Immediately after intervention

Secondary Outcomes (1)

  • Assessment of bronchoscopy realisation and sample collection

    Immediately after intervention

Study Arms (1)

virtual reality

EXPERIMENTAL

virtual reality headset

Device: virtual reality device

Interventions

20 minutes session with virtual reality device

virtual reality

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients with no age or gender restrictions, seen on an outpatient basis at Le Mans Hospital.
  • In whom bronchial fibroscopy is indicated.
  • Person affiliated with or benefiting from a social security .
  • Patient able and willing to answer questionnaires

You may not qualify if:

  • Patient refusing to participate in research
  • Patient who has already undergone bronchoscopy in vigil
  • Patient premedicated for bronchial fibroscopy (anxiolytic, etc.)
  • Patients with a history of epilepsy or psychiatric pathology
  • Patient with vertigo
  • Patient uncooperative, demented or unable to tolerate headgear.
  • patient under guardianship or curatorship
  • Patients suffering from blindness or deafness
  • Patient with known significant intolerance to screens and/or virtual reality devices
  • Pregnant, nursing or parturient women
  • Unscheduled patients: emergencies, etc.
  • Hospitalized patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Le Mans

Le Mans, 72000, France

RECRUITING

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Christine PETIT

    Centre Hospitalier le Mans

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christelle JADEAU

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: single-center, prospective, interventional study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2025

First Posted

January 29, 2025

Study Start

February 27, 2025

Primary Completion

February 27, 2026

Study Completion

February 27, 2026

Last Updated

March 24, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations